A Phase 1, Open-label, Drug Interaction Study Evaluating the Pharmacokinetic Profiles of SPD489 and EFFEXOR XR, Administered Alone and in Combination in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Lisdexamfetamine; Venlafaxine
- Indications Anxiety disorders; Depression; Social phobia
- Focus Pharmacokinetics
- Sponsors Shire
- 04 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Dec 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Nov 2010 New trial record